Abstract
Senior Editor Eliza Strickland [top] was dazzled when she heard about the first retinal implant approved to restore vision to the blind. That was back in 2011, when the system-the first commercial device to provide artificial vision by using electrodes to stimulate retinal cells-was approved in Europe and was poised for approval in the United States. While the vision was extremely crude, early adopters were told they'd get upgrades as the device's maker, Second Sight Medical Products, improved it.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
